// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Risk Air Quality for Recruited RCMP Officers in 2016 Fort McMurray Wildfires: Is There a Health Impact from Short Periods of Intense Wildfire Smoke Exposure?

N. Miandashti - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A Simple Method to Assess Lung Recruitability at the Bedside for Patients with Acute Respiratory Distress Syndrome

L. Chen - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Rifampin Containing Regimen for the Treatment of Active Tuberculosis (TB) in Patients with Rifampin Allergy

J. Batt - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Rifampin Injection

Female Sex Hormones Can Prevent but Not Reverse Established Pulmonary Arterial Hypertension in the SU5416/Chronic Hypoxia Model

K. R. Chaudhary - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

SU5416

Primary Ciliary Dyskinesia (PCD) Registry in Alberta

R. Har-Even Cohn - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Mortality of Pediatric Surgical Lung Biopsy in Ontario, Canada

W. B. Wee - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Mean Curvature of Isophotes: A Novel Quantitative CT Metric with Improved Discrimination Between Early COPD and Healthy Subjects

P. Savadjiev - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Impact of a Regional Multidisciplinary Conference on the Diagnosis of Interstitial Lung Disease

J. Grewal - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Moral Distress in Critical Care Physicians: Contextual and Relational Causes, Individual and Collective Consequences

D. Piquette - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Active Coping in Medical Students Is Associated with Less Burnout and Higher Resilience

P. M. Dodek - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

High Prevalence of Burnout Despite Low Levels of Moral Distress and High Resilience Scores in Medical Students

P. M. Dodek - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Inducing Oxidative DNA Damage Overload by Inhibiting the 8oxoguanine Hydrolase MTH1 to Kill Pulmonary Artery Smooth Muscle Cells: A New Therapeutic Strategy in Pulmonary Arterial Hypertension

G. Vitry - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Middle Income Countries Are Underrepresented in Leading Respirology and Critical Care Journals

Y. Khan - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Impact of Gender on Clinical Evaluation of Trainees in the Intensive Care Unit

J. Spring - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Audiovisual Tool Use to Impact ICU Patients' Surrogates Level of Anxiety: A Preliminary Descriptive Analysis

T. M. Ferrer Marrero - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Selective Digestive Decontamination in the ICU: A Dynamic Population, Microsimulation Model

M. Schmidt - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Methicillin-resistant Staphylococcus aureus (MRSA) infection

vancomycin capsule

Improving Advance Care Planning for People with IPF

M. Kalluri - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Idiopathic pulmonary fibrosis

N/A

Chronic Obstructive Pulmonary Disease (COPD) Shifts Alveolar Macrophage Polarization Towards Senescence Phenotype

K. Akata - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Targeted Approach to Cell Cycle Regulation and Cancer Therapy

A. Das Gupta - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Hypopnea in Pregnant Women

N. Goldscher Minerbi - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Copyright © 2026. QuantiNova All rights reserved